{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:02Z","timestamp":1790985242804,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08564-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:27:58Z","timestamp":1783513678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-1374","authenticated-orcid":false,"given":"Salvatore","family":"Corrao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"8564_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137. https:\/\/doi.org\/10.1038\/nature05485.","journal-title":"Nature"},{"key":"8564_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219\u201346.","journal-title":"Annu Rev Physiol"},{"key":"8564_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85\u201397.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8564_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11883-014-0409-1","volume":"16","author":"HE Bays","year":"2014","unstructured":"Bays HE. Adiposopathy, sick fat, Ockham\u2019s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16(5):409. https:\/\/doi.org\/10.1007\/s11883-014-0409-1.","journal-title":"Curr Atheroscler Rep"},{"key":"8564_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/obr.70155","author":"S Corrao","year":"2026","unstructured":"Corrao S, Tuccinardi D, Baratta R. Beyond weight loss: obesogenic memory as a form of biological hysteresis in adipose tissue revealed by AI-driven semantic mapping. Obes Rev. 2026. https:\/\/doi.org\/10.1111\/obr.70155.","journal-title":"Obes Rev"},{"key":"8564_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.70134","volume":"0","author":"JF Merola","year":"2026","unstructured":"Merola JF, Mease P, Kivitz A, Sattar N, Coates LC, Aletaha D, et al. Ixekizumab with tirzepatide achieved greater disease control than ixekizumab alone in adults with psoriatic arthritis and overweight or obesity: results from a randomized clinical trial. Arthritis Rheumatol. 2026;0:1\u201313. https:\/\/doi.org\/10.1002\/art.70134.","journal-title":"Arthritis Rheumatol"},{"key":"8564_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol. 2018;55:379\u201390.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"8564_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981\u20131000. https:\/\/doi.org\/10.1016\/j.autrev.2014.07.001.","journal-title":"Autoimmun Rev"},{"issue":"6284","key":"8564_CR9","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG, et al. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352(6284):aaf1098. https:\/\/doi.org\/10.1126\/science.aaf1098.","journal-title":"Science"},{"key":"8564_CR10","doi-asserted-by":"publisher","first-page":"1684641","DOI":"10.3389\/fmed.2025.1684641","volume":"12","author":"S Corrao","year":"2025","unstructured":"Corrao S, Scibetta S, Calvo L, Lo Monaco M, Mallaci Bocchio R, Natoli G, et al. Central obesity in psoriatic arthritis: associations with disease activity, function, and quality of life in a real-world cohort. Front Med (Lausanne). 2025;12:1684641. https:\/\/doi.org\/10.3389\/fmed.2025.1684641.","journal-title":"Front Med (Lausanne)"},{"key":"8564_CR11","doi-asserted-by":"publisher","first-page":"1668159","DOI":"10.3389\/fimmu.2026.1668159","volume":"17","author":"S Corrao","year":"2026","unstructured":"Corrao S, Scibetta S, Pardo N, Cangemi I, Mirarchi L, Corrao G, et al. Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases. Front Immunol. 2026;17:1668159. https:\/\/doi.org\/10.3389\/fimmu.2026.1668159.","journal-title":"Front Immunol"},{"key":"8564_CR12","doi-asserted-by":"publisher","first-page":"1402583","DOI":"10.3389\/fendo.2024.1402583","volume":"15","author":"S Corrao","year":"2024","unstructured":"Corrao S, Pollicino C, Maggio D, Torres A, Argano C. Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence. Front Endocrinol (Lausanne). 2024;15:1402583. https:\/\/doi.org\/10.3389\/fendo.2024.1402583.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8564_CR13","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.eclinm.2022.101737","volume":"55","author":"S Verma","year":"2022","unstructured":"Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, Kandler K, Kushner RF, Rubino DM, Kosiborod MN. Effects of once-weekly semaglutide 2.4\u00a0mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials. EClinicalMedicine. 2022;55:101737. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101737.","journal-title":"EClinicalMedicine"},{"key":"8564_CR14","doi-asserted-by":"publisher","first-page":"643144","DOI":"10.3389\/fimmu.2021.643144","volume":"12","author":"I Efimova","year":"2021","unstructured":"Efimova I, Steinberg I, Zvibel I, Neumann A, Mantelmacher DF, Drucker DJ, Fishman S, Varol C. GIPR signaling in immune cells maintains metabolically beneficial type 2 immune responses in the white fat from obese mice. Front Immunol. 2021;12:643144. https:\/\/doi.org\/10.3389\/fimmu.2021.643144.","journal-title":"Front Immunol"},{"issue":"3","key":"8564_CR15","doi-asserted-by":"publisher","first-page":"e174825","DOI":"10.1172\/jci.insight.174825","volume":"10","author":"R Hammoud","year":"2024","unstructured":"Hammoud R, Kaur KD, Koehler JA, Baggio LL, Wong CK, Advani KE, Yusta B, Efimova I, Gribble FM, Reimann F, Fishman S, Varol C, Drucker DJ. Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice. JCI Insight. 2024;10(3):e174825. https:\/\/doi.org\/10.1172\/jci.insight.174825.","journal-title":"JCI Insight"},{"key":"8564_CR16","doi-asserted-by":"publisher","first-page":"171200","DOI":"10.1016\/j.peptides.2024.171200","volume":"176","author":"NM Morrow","year":"2024","unstructured":"Morrow NM, Morissette A, Mulvihill EE. Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut. Peptides. 2024;176:171200. https:\/\/doi.org\/10.1016\/j.peptides.2024.171200.","journal-title":"Peptides"},{"issue":"7","key":"8564_CR17","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, Aihara E, Christe ME, Varga G, Beyer TP, Ruan X, Beebe E, O\u2019Farrell LS, Bellinger MA, Austin AK, Lin Y, Hu H, Konkol DL, Wojnicki S, Holland AK, Friedrich JL, Brown RA, Estelle AS, Badger HS, Gaidosh GS, Kooijman S, Rensen PCN, Coskun T, Thomas MK, Roell W. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab. 2024;36(7):1534\u2013e15497. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.010.","journal-title":"Cell Metab"},{"issue":"8","key":"8564_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","volume":"18","author":"LC Coates","year":"2022","unstructured":"Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465\u201379. https:\/\/doi.org\/10.1038\/s41584-022-00798-0.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08564-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08564-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08564-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:09Z","timestamp":1790982189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08564-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8564"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08564-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics declaration and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1236"}}